LMAT LeMaitre Vascular, Inc.
$80.59▲ +2.27%
Healthcare
Other
After hours
$80.59▲ +0.00%
Sep 11, 7:30 PM ET
Volume 279.0K
Avg Volume (10D) 259.3K
Key Metrics & Fundamentals
Market Cap
$1.84B
P/E Ratio
28.2
Div Yield
1.27%
52W Range
78.27 - 118.01
% vs 50 MA
-13.16%
% vs 200 MA
-16.94%
RSI-14
34.9
MACD Histogram
+0.4700
Beta (1Y vs SPY)
0.46
Free Cash Flow
$13.65M
Gross Rev
$70.38M
Gross Profit
$50.76M
EBITDA
$26.15M
COGS
$19.62M
Operating Exp
$30.37M
Operating Income
$20.40M
EBIT
$20.40M
Pretax Income
$22.19M
Net Income
$17.05M
EPS (Diluted)
0.74
Price & Volume History
Loading chart…
Recent News
3 Out-of-Favor Stocks with Questionable Fundamentals
StockStory · Sep 4, 2026 7:58 AM
PAHC or LMAT: Which Is the Better Value Stock Right Now?
Zacks · Sep 2, 2026 3:40 PM
Speculative Rally Weighed on LeMaitre Vascular (LMAT)
Insider Monkey · Sep 1, 2026 1:06 PM
LeMaitre to Participate at Upcoming Investor Conferences in September
GlobeNewswire · Aug 27, 2026 8:51 PM
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
StockStory · Aug 15, 2026 6:53 PM
GEHC or LMAT: Which Is the Better Value Stock Right Now?
Zacks · Aug 13, 2026 3:40 PM
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call
StockStory · Aug 13, 2026 8:37 AM
LeMaitre Vascular (LMAT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 12:30 AM
31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update
Simply Wall St. · Aug 8, 2026 1:11 AM
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
GlobeNewswire · Aug 6, 2026 9:15 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LMAT's money flow as a full page
Social Sentiment
No Reddit posts found for LMAT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.